Assessment of the efficacy of successive endocrine therapies in hormone receptor –positive and HER2-negative metastatic breast cancer: a real-life multicentre national study

For luminal metastatic breast cancer (MBC), endocrine therapy (ET) is the recommended initial treatment before chemotherapy. Our objective was to evaluate the efficacy of multiple ET lines in a real-life study.

Source: European Journal of Cancer - July 19, 2019 Category: Cancer & Oncology Authors: Olivia Le Saux, Audrey Lardy-Cleaud, Sophie Frank, Marc Debled, Paul H. Cottu, Barbara Pistilli, Laurence Vanlemmens, Marianne Leheurteur, Christelle L évy, Lilian Laborde, Lionel Uwer, Veronique D'hondt, Delphine Berchery, Veronique Lorgis, Jean-Marc Fe Tags: Original Research Source Type: research